Ramsay Stattman Vela & Price Inc. Reduces Stake in Danaher Corporation $DHR

Ramsay Stattman Vela & Price Inc. cut its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 5.4% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 59,817 shares of the conglomerate’s stock after selling 3,409 shares during the quarter. Danaher accounts for 2.2% of Ramsay Stattman Vela & Price Inc.’s investment portfolio, making the stock its 15th biggest holding. Ramsay Stattman Vela & Price Inc.’s holdings in Danaher were worth $11,341,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter worth $25,000. WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter valued at about $26,000. Elevated Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter valued at about $26,000. Hilton Head Capital Partners LLC purchased a new position in Danaher during the 4th quarter valued at about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its position in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of NYSE DHR opened at $195.75 on Friday. The company has a market cap of $138.54 billion, a PE ratio of 37.86, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The company has a 50-day simple moving average of $180.18 and a 200-day simple moving average of $199.48.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the firm posted $1.88 earnings per share. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, equities analysts anticipate that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent research reports. Robert W. Baird reduced their price target on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a report on Friday, April 17th. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price objective on shares of Danaher in a research note on Tuesday, April 21st. Argus cut their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Finally, Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $233.52.

View Our Latest Research Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.